Quantitative medical cost-effectiveness analysis of molecular-targeting cancer drugs in Japan

BACKGROUND: In Japan, both incidence and mortality rates of cancers have continuously increased and medical costs are growing more rapidly than the overall economy of Japan. However, there is no consensus threshold for cost-effectiveness in medical care, and few studies have investigated cost-effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebara, Takeshi, Ohno, Tatsuya, Nakano, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679802/
https://www.ncbi.nlm.nih.gov/pubmed/23706012
http://dx.doi.org/10.1186/2008-2231-21-40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679802/
https://www.ncbi.nlm.nih.gov/pubmed/23706012
http://dx.doi.org/10.1186/2008-2231-21-40

Ejemplares similares